HILSX | OAZIX | HILSX / OAZIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 14 years | 4 years | - |
Gain YTD | 10.148 | 1.307 | 776% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.41B | 18.4B | 29% |
Annual Yield % from dividends | 2.32 | 2.16 | 107% |
Returns for 1 year | 20.01 | 13.39 | 149% |
Returns for 3 years | 23.86 | -4.13 | -577% |
Returns for 5 years | 49.66 | N/A | - |
Returns for 10 years | 64.08 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETIHX | 37.68 | 0.84 | +2.28% |
Eventide Healthcare & Life Sciences I | |||
HAGCX | 55.59 | 0.29 | +0.52% |
Carillon Eagle Mid Cap Growth C | |||
MASCX | 12.69 | 0.06 | +0.48% |
BlackRock Sustainable Advantage GlEqInvA | |||
RICIX | 10.72 | 0.01 | +0.09% |
T. Rowe Price Intl Disciplined Eq I | |||
TNVRX | 17.91 | N/A | N/A |
1290 GAMCO Small/Mid Cap Value R |